Burleson Tess 4
4 · Salarius Pharmaceuticals, Inc. · Filed Sep 13, 2019
Insider Transaction Report
Form 4
Burleson Tess
Director
Transactions
- Award
Stock Option (right to buy)
2019-09-10+3,000→ 3,000 totalExercise: $8.00From: 2019-12-31Exp: 2029-09-10→ Common Stock (3,000 underlying)